Florida Senate - 2014 SB 408 By Senator Braynon 36-00457-14 2014408__ 1 A bill to be entitled 2 An act relating to a needle and syringe exchange pilot 3 program; amending s. 381.0038, F.S.; requiring the 4 Department of Health to establish a needle and syringe 5 exchange pilot program in Miami-Dade County; providing 6 for administration of the pilot program by the 7 department or a designee; establishing pilot program 8 criteria; providing that the distribution of needles 9 and syringes under the pilot program is not a 10 violation of the Florida Comprehensive Drug Abuse 11 Prevention and Control Act or any other law; providing 12 conditions under which a pilot program staff member or 13 participant may be prosecuted; prohibiting the 14 collection of participant identifying information; 15 providing for the pilot program to be funded through 16 private grants and donations; providing for expiration 17 of the pilot program; requiring a report to the 18 Legislature; providing rulemaking authority; providing 19 for severability; providing an effective date. 20 21 Be It Enacted by the Legislature of the State of Florida: 22 23 Section 1. Section 381.0038, Florida Statutes, is amended 24 to read: 25 381.0038 Education; needle and syringe exchange pilot 26 program.—The Department of Health shall establish a program to 27 educate the public about the threat of acquired immune 28 deficiency syndrome and a sterile needle and syringe exchange 29 pilot program. 30 (1) The acquired immune deficiency syndrome education 31 program shall: 32 (a) Be designed to reach all segments of Florida’s 33 population; 34 (b) Contain special components designed to reach non 35 English-speaking and other minority groups within the state; 36 (c) Impart knowledge to the public about methods of 37 transmission of acquired immune deficiency syndrome and methods 38 of prevention; 39 (d) Educate the public about transmission risks in social, 40 employment, and educational situations; 41 (e) Educate health care workers and health facility 42 employees about methods of transmission and prevention in their 43 unique workplace environments; 44 (f) Contain special components designed to reach persons 45 who may frequently engage in behaviors placing them at a high 46 risk for acquiring acquired immune deficiency syndrome; 47 (g) Provide information and consultation to state agencies 48 to educate all state employees; and 49 (h) Provide information and consultation to state and local 50 agencies to educate law enforcement and correctional personnel 51 and inmates. 52 (i) Provide information and consultation to local 53 governments to educate local government employees. 54 (j) Make information available to private employers and 55 encourage them to distribute this information to their 56 employees. 57 (k) Contain special components which emphasize appropriate 58 behavior and attitude change. 59 (l) Contain components that include information about 60 domestic violence and the risk factors associated with domestic 61 violence and AIDS. 62 (2) The education program designed by the Department of 63 Health shall utilize all forms of the media and shall place 64 emphasis on the design of educational materials that can be used 65 by businesses, schools, and health care providers in the regular 66 course of their business. 67 (3) The department may contract with other persons in the 68 design, development, and distribution of the components of the 69 education program. 70 (4) The department shall establish a sterile needle and 71 syringe exchange pilot program in Miami-Dade County. The pilot 72 program shall be administered by the department or the 73 department’s designee. The department may designate one of the 74 following entities to operate the pilot program at a fixed 75 location or through a mobile health unit: a hospital licensed 76 under chapter 395, a health care clinic licensed under part X of 77 chapter 400, a substance abuse treatment program, an HIV or AIDS 78 service organization, or another nonprofit entity designated by 79 the department. The pilot program shall offer the free exchange 80 of clean, unused needles and hypodermic syringes for used 81 needles and hypodermic syringes as a means to prevent the 82 transmission of HIV, AIDS, viral hepatitis, or other blood-borne 83 diseases among intravenous drug users and their sexual partners 84 and offspring. 85 (a) The pilot program shall: 86 1. Provide for maximum security of exchange sites and 87 equipment, including an accounting of the number of needles and 88 syringes in use, the number of needles and syringes in storage, 89 safe disposal of returned needles, and any other measure that 90 may be required to control the use and dispersal of sterile 91 needles and syringes. 92 2. Strive for a one-to-one exchange, whereby the 93 participant shall receive one sterile needle and syringe unit in 94 exchange for each used one. 95 3. Make available educational materials; HIV counseling and 96 testing; referral services to provide education regarding HIV, 97 AIDS, and viral hepatitis transmission; and drug-use prevention 98 and treatment. 99 (b) Notwithstanding any other provision of law, the 100 possession, distribution, or exchange of needles or syringes as 101 part of a needle and syringe exchange pilot program established 102 by the department or the department’s designee is not a 103 violation of any part of chapter 893 or any other law. 104 (c) A needle and syringe exchange pilot program staff 105 member, volunteer, or participant is not immune from criminal 106 prosecution for: 107 1. The possession of needles or syringes that are not a 108 part of the exchange pilot program; or 109 2. Redistribution of needles or syringes in any form, if 110 acting outside the pilot program. 111 (d) The pilot program shall collect data for annual and 112 final reporting purposes, which shall include information on the 113 number of participants served, the number of needles and 114 syringes exchanged and distributed, the demographic profiles of 115 the participants served, the number of participants entering 116 drug counseling and treatment, the number of participants 117 receiving HIV, AIDS, or viral hepatitis testing, and other data 118 deemed necessary for the pilot program. However, personal 119 identifying information may not be collected from a participant 120 for any purpose. 121 (e) State funds may not be used to operate the pilot 122 program. The pilot program shall be funded through grants and 123 donations from private resources and funds. 124 (f) The pilot program shall expire July 1, 2019. Six months 125 before the pilot program expires, the Office of Program Policy 126 Analysis and Government Accountability shall submit a report to 127 the President of the Senate and the Speaker of the House of 128 Representatives which includes the data collection requirements 129 established in this subsection; the rates of HIV, AIDS, viral 130 hepatitis, or other blood-borne diseases before the pilot 131 program began and every subsequent year thereafter; and a 132 recommendation on whether to continue the pilot program. 133 (g) The department may adopt and develop rules to 134 administer this subsection. 135 Section 2. If any provision of this act or its application 136 to any person or circumstance is held invalid, the invalidity 137 does not affect other provisions or applications of the act that 138 can be given effect without the invalid provision or 139 application, and to this end the provisions of this act are 140 severable. 141 Section 3. This act shall take effect July 1, 2014.